How Node-RADS and ADC Transform Breast Cancer Staging

Evaluating axillary lymph nodes is crucial for guiding treatment in breast cancer. However, clinicians often face challenges due to the lack of a standardized radiological assessment method. Recently, researchers evaluated the utility of Node-RADS breast cancer imaging assessments to solve this diagnostic dilemma. Specifically, a new study demonstrates how combining Node-RADS scores with apparent diffusion coefficient (ADC) values dramatically enhances diagnostic accuracy.

Standardizing Nodal Evaluation with Node-RADS breast cancer Scoring

Standardized reporting systems offer great consistency across diverse clinical settings. Therefore, investigators retrospectively assessed Node-RADS scores for axillary lymph nodes in breast cancer patients. Consequently, they found that Node-RADS serves as a highly reliable tool for identifying metastasis. In particular, a Node-RADS score greater than 2 emerged as the optimal cutoff value. Furthermore, the standardized framework helps eliminate inter-reader variability. This approach allows radiologists to communicate findings more clearly to the oncology team.

The Synergistic Power of Combining Node-RADS and ADC

While morphology provides critical clues, functional imaging adds deep physiological insights. For this reason, the research team measured the apparent diffusion coefficient (ADC) of the lymph nodes and primary tumors. Specifically, they calculated both calibrated ADC (cADC) and relative ADC (rADC) values. Subsequently, they integrated these quantitative measurements with the qualitative Node-RADS scores. The resulting combined predictive model demonstrated outstanding diagnostic performance in clinical tests. Indeed, it achieved impressive area under the curve (AUC) values in both internal and external validation datasets.

Clinical Implications for Oncology Practices in India

Breast cancer remains the most prevalent malignancy among Indian women today. Thus, clinicians need precise, non-invasive staging tools to avoid unnecessary surgical axillary dissections. This combined model provides a practical solution for busy oncology practices across India. Moreover, the integration of cADC and Node-RADS requires no additional expensive software. Radiologists can easily implement this workflow on standard MRI machines. Consequently, Indian oncologists can better tailor personalized treatment strategies for their patients.

Frequently Asked Questions

Q1: What is the optimal cutoff score for Node-RADS in evaluating axillary lymph node metastasis?

The study identified a Node-RADS score greater than 2 as the optimal cutoff value. Consequently, this threshold offers a reliable benchmark for identifying metastasis.

Q2: How does the combination of Node-RADS and ADC improve diagnostic accuracy?

Specifically, combining morphological Node-RADS scores with calibrated ADC values merges anatomical and physiological data. As a result, the integrated model delivers a much more precise and reliable diagnosis.

Q3: Was this predictive model validated across multiple patient cohorts?

Yes, investigators tested the model on both internal and external datasets. Indeed, the model maintained high predictive performance across both validation cohorts.

References

1. Han L et al. Combining Node-RADS with ADC can improve diagnostic performance for lymph node metastasis in breast cancer. Eur Radiol. 2026 Jun 03. doi: 10.1007/s00330-026-12649-7. PMID: 42236540.
2. Kim HJ et al. Node Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular Carcinoma. Radiology. 2025 Sep 02. doi: 10.1148/radiol.250550.